Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation - Tabular View

Tracking Information

First Received Date ^ICMJE

September 12, 2005

Last Updated Date

June 17, 2009

Start Date ^ICMJE

October 2003

Primary Completion Date

July 2006 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

resolution of abnormal fetal heart tracing

Original Primary Outcome Measures ^ICMJE

resolution of abnormal fetal heart tracing

Change History

Complete list of historical versions of study NCT00185887 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

cesarean section rate
operative vaginal delivery rate
neonatal outcomes

Original Secondary Outcome Measures ^ICMJE

cesarean section rate
operative vaginal delivery rate
neonatal outcomes

Descriptive Information

Brief Title ^ICMJE

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Official Title ^ICMJE

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Brief Summary

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Detailed Description

Study Phase

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment

Condition ^ICMJE

Fetal Distress

Intervention ^ICMJE

Drug: nitroglycerin and terbutaline

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

110

Completion Date

October 2007

Primary Completion Date

July 2006 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria::

nonreassuring fetal heart rate tracing

Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section

Gender

Female

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00185887

Responsible Party

Yasser Yehia El-Sayed, Principal Investigator, Stanford University School of Medicine

Study ID Numbers ^ICMJE

79504

Study Sponsor ^ICMJE

Stanford University

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Yasser Yehia El-Sayed

Stanford University

Information Provided By

Stanford University

Verification Date

May 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP